CRISPR technology allows for precise DNA modifications, holding promise for treating genetic disorders and revolutionizing ...

In a potential advance for melanoma patients, researchers at ChristianaCare's Gene Editing Institute have used CRISPR gene ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

While the Nobel-winning genome-editing technology CRISPR holds great promise, Duke’s Center for Advanced Genomic Technologies ...

The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate, or grow ...

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $48.05, representing a +0.47% change from its previous close.

Our current food system is facing a myriad of critical challenges. The United Nations predicts that the world population will ...

A study reveals that CRISPR gene editing can disable a mutation in melanoma cells that leads to treatment resistance. By targeting the NRAS gene mutation, researchers restored the cells' sensitivity ...

In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms of ...

On The Readout LOUD, John Maraganore discusses his new startup, and STAT's Megan Molteni tells the latest about "CRISPR baby" ...

This diverse set of growth stocks offers tremendous opportunities in the fields of AI, space, biotech, and emerging ...

A collaborative effort between investigators at the National Institutes of Health's National Institute of Allergy and ...